Proton pump inhibitors overuse - consequences among patients
Introduction Omeprazole was first proton pump inhibitor (PPI) approved for use by patients. Thirty years have passed since then. Due to their effectiveness, low price and safety proton pump inhibitors have become one of the most frequently prescribed medicines in the world. In recent years, more att...
Saved in:
Main Authors: | Patrycja Kmiotek (Author), Andrzej Materniak (Author), Barbara Skrzydło-Radomańska (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2019-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019) -
The consequences of long-term therapy with proton pump inhibitors
by: Zuzanna Drygała, et al.
Published: (2024) -
Proton pump inhibitor (PPI) administration and Clostridioides difficile infection - is this a real clinical problem? A critical review of the literature
by: Aneta Głaz, et al.
Published: (2023) -
Proton pump inhibitors in pediatric practice
by: Anna A. Shilova, et al.
Published: (2023) -
Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021)